Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

RKTO vs ADTX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ADTX Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 8–2 Matrix Metrics)

ADTX Overall Winner 6-Pillar Tally: RKTO 0 – 4 ADTX (2 Tie) Matrix Metrics: RKTO 2 – 8 ADTX

As of Nov 20, 2026, Aditxt, Inc. (ADTX) is the stronger overall head-to-head candidate over RKTO (RKTO) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RKTO carries a Unified Composite Score of 44.2/100 (HOLD) at $0.30 (N/M Forward P/E, N/A operating margin), whereas ADTX carries 50.4/100 (HOLD) at $0.01 (0.3x Forward P/E, -35873.5% operating margin).

  • Technical & Structure Timing Caution: RKTO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.8); meanwhile ADTX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RKTO vs ADTX
RKTO US Equity
RKTO
Institutional Equity
$0.30
+6.11% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.16β · 63% Vol
Unified Composite Score
44.2 / 100 HOLD
Tech 45.0 Fund 42.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -18.1%), weak momentum, RSI 22
RSI-14: 21.8 · SMA20: $0.40 · SMA50: $0.56
ADTX NASDAQ Head-to-Head Winner
Aditxt, Inc. Common Stock
Pharmaceutical Preparations
$0.01
-77.22% 1D
Market Cap $34,023
TTM Revenue $14,336
Forward P/E 0.3x
Beta / 30D Vol 13.77β · 831% Vol
Unified Composite Score
50.4 / 100 HOLD
Tech 45.0 Fund 51.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -56.7%), weak momentum, RSI 39
RSI-14: 38.7 · SMA20: $0.06 · SMA50: $0.26

6-Pillar Scorecard Institutional Category Breakdown (RKTO 0 – 4 ADTX)

Columns: Metric · RKTO · ADTX
1. Valuation Multiples ADTX
Forward P/E N/M 0.3x
Trailing P/E N/M 0.3x
PEG Ratio N/M N/M
EV / Revenue N/M 2.4x
2. Growth & Scale ADTX
Revenue Growth (YoY) N/A +1094.4%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $14,336
Market Cap N/A $34,023
3. Profitability & Quality ADTX
Gross Margin N/A 19.9%
Operating Margin N/A -35873.5%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A -699.1%
4. Balance Sheet & Cash Flow ADTX
Cash Generation (TTM) N/A -$18M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE -699.1% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RKTO (2) vs ADTX (8)
Institutional Metric RKTO ADTX Criterion Row Edge
Market Capitalization
Scale
N/A $34,023 Larger Scale ADTX
Trailing P/E Ratio
Valuation
N/M 0.3x Lower Multiple ADTX
Forward P/E Ratio
Valuation
N/M 0.3x Lower Multiple ADTX
Revenue Growth (YoY)
Growth
N/A +1094.4% Higher Growth ADTX
Operating Margin (TTM)
Profitability
N/A -35873.5% Higher Margin ADTX
Net Profit Margin
Profitability
N/A 0.0% Higher Margin ADTX
Return on Equity (ROE)
Capital Efficiency
N/A -699.1% Higher ROE ADTX
52-Week Range Position
Momentum
2% ($0–$2) 0% ($0–$7) Stronger Trend RKTO
Beta / 30D Volatility
Risk Regime
1.16β · 63% Vol 13.77β · 831% Vol Lower Realized Risk RKTO
Unified Institutional Score
Composite Signal
44.2 / 100 (HOLD) 50.4 / 100 (HOLD) Higher Composite ADTX
Trailing 12M Revenue (USD)
Operating Scale
N/A $14,336 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 19.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 2.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$18M EBITDA (-699.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon RKTO +53.62 pp
RKTO: -40.59% · ADTX: -94.21%
3M Horizon RKTO +53.62 pp
RKTO: -40.59% · ADTX: -94.21%
6M Horizon RKTO +53.62 pp
RKTO: -40.59% · ADTX: -94.21%
1Y Horizon RKTO +53.62 pp
RKTO: -40.59% · ADTX: -94.21%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RKTO vs ADTX. Trailing 12-month operating profitability (RKTO N/A vs ADTX -35873.5%) and valuation multiples (RKTO N/M vs ADTX 0.3x Forward P/E) are benchmarked directly in Pillar 4 below.

RKTO ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
ADTX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14,336
Gross Margin19.9%
Op. Margin-35873.5%
ROE / Fwd P/E-699.1% · 0.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RKTO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RKTO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ADTX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ADTX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RKTO Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ADTX Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $34,023 market capitalization and -35873.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ RKTO vs ADTX Key Questions & Quantitative Answers

As of Nov 20, 2026, Aditxt, Inc. (ADTX) is the stronger overall head-to-head candidate over RKTO (RKTO) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RKTO carries a Unified Composite Score of 44.2/100 (HOLD) at $0.30 (N/M Forward P/E, N/A operating margin), whereas ADTX carries 50.4/100 (HOLD) at $0.01 (0.3x Forward P/E, -35873.5% operating margin). Technical & Structure Timing Caution: RKTO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.8); meanwhile ADTX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ADTX leads the Growth & Scale pillar: RKTO posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ADTX at +1094.4% YoY revenue growth and +0.0% YoY earnings growth on $14,336 TTM revenue (19.9% gross margin, -35873.5% operating margin). On trailing 12-month operating scale, RKTO generates N/A in USD-normalized revenue versus $14,336 for ADTX. In operating R&D and SG&A reinvestment, RKTO deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ADTX.

ADTX screens cheaper on headline valuation multiples. RKTO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ADTX trades at 0.3x Forward P/E, 0.3x Trailing P/E, N/M PEG, and 2.4x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RKTO (N/A ROE) versus ADTX (-699.1% ROE) capital efficiency.

In options market volatility and institutional positioning, RKTO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.16β · 63% Vol realized risk). By comparison, ADTX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (13.77β · 831% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.